Your browser doesn't support javascript.
COVID-19 point-of-care testing in care homes: what are the lessons for policy and practice?
Buckle, Peter; Micocci, Massimo; Tulloch, John; Kierkegaard, Patrick; Parvulescu, Paula; Thompson, Carl; Spilsbury, Karen; Allen, A Joy; Body, Richard; Hayward, Gail; Buchan, Iain; Gordon, Adam L.
  • Buckle P; NIHR London In-Vitro Diagnostics Cooperative, Imperial College London, London, UK.
  • Micocci M; NIHR London In-Vitro Diagnostics Cooperative, Imperial College London, London, UK.
  • Tulloch J; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Kierkegaard P; NIHR London In-Vitro Diagnostics Cooperative, Imperial College London, London, UK.
  • Parvulescu P; Department of Public Health, Liverpool City Council, Liverpool, UK.
  • Thompson C; School of Healthcare, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
  • Spilsbury K; NIHR Applied Research Collaboration-Yorkshire and Humber (YHARC), Leeds, UK.
  • Allen AJ; School of Healthcare, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
  • Body R; NIHR Applied Research Collaboration-Yorkshire and Humber (YHARC), Leeds, UK.
  • Hayward G; NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle University, Newcastle upon Tyne, UK.
  • Buchan I; Division of Cardiovascular Science, The University of Manchester, Manchester, UK.
  • Gordon AL; Emergency Department, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Age Ageing ; 50(5): 1442-1444, 2021 09 11.
Article in English | MEDLINE | ID: covidwho-1226520
ABSTRACT
COVID-19 has devastated care homes. Point-of-care tests (POCTs), mainly using lateral flow devices (LFDs), have been deployed hurriedly without much consideration of their usability or impact on care workflow. Even after the pandemic, POCTs, particularly multiplex tests, may be an important control against spread of SARS-CoV-2 and other respiratory infections in care homes by enabling identification of cases. They should not, however, replace other infection control measures such as barrier methods and quarantine. Adherence to LFDs as implemented among care home staff is suboptimal. Other tests-such as point-of-care polymerase chain reaction and automated antigen tests-would also need to be accommodated into care home workflows to improve adherence. The up-front costs of POCTs are straightforward but additional costs, including staffing preparation and reporting processes and the impacts of false positive and negative tests on absence rates and infection days, are more complex and as yet unquantified. A detailed appraisal is needed as the future of testing in care homes is considered.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Age Ageing Year: 2021 Document Type: Article Affiliation country: Ageing

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Age Ageing Year: 2021 Document Type: Article Affiliation country: Ageing